FDA 21 CFR 820.80 Compliance Toolkit
6 ready-to-use, audit-tested documents that bring your incoming inspection process into full compliance — in hours, not weeks.
Your incoming inspection process lives in people's heads — not in a controlled document an auditor can review.
Every inspector does it differently. Some check dimensions, some don't. Sampling plans? Nobody can explain the rationale.
You know 820.80 requires documented incoming inspection, but you're not confident your records would survive an FDA investigator.
6 professionally written documents, ready to customize and deploy
Step-by-step procedure aligned to 21 CFR 820.80(b). Covers responsibilities, acceptance criteria, sampling requirements, and documentation flow.
Standardized checklist for inspecting incoming components, raw materials, and sub-assemblies. Ready for immediate use on the receiving dock.
Professional CoC template to send to or receive from suppliers. Pre-formatted with all required fields per FDA and ISO 13485 expectations.
Calculate statistically valid sample sizes using ANSI/ASQ Z1.4 tables. Includes normal, tightened, and reduced inspection levels.
Document and disposition nonconforming incoming materials. Tracks MRB decisions, supplier notifications, and CAPA linkage.
Risk-based matrix mapping each supplier and part number to specific inspection requirements, skip-lot eligibility, and historical performance.
“We passed our FDA audit two weeks after implementing this toolkit. The sampling plan worksheet alone saved us 10+ hours.”
Sarah M.
QA Manager, Class II Device Manufacturer
“Finally, a complete incoming inspection package that actually matches what auditors expect to see. Worth every penny.”
David R.
Regulatory Affairs Director
Stop building inspection documents from scratch. Get 6 audit-ready templates and have your incoming inspection process documented by end of day.
Instant download · Editable Word & Excel formats